• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔癌无肿瘤淋巴结中 CD40L 的低表达与预后不良相关。

Low expression of CD40L in tumor-free lymph node of oral cavity cancer related with poor prognosis.

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.

Department of Otorhinolaryngology-Head and Neck Surgery, Korea University Ansan Hospital, Ansan, South Korea.

出版信息

Int J Clin Oncol. 2018 Oct;23(5):851-859. doi: 10.1007/s10147-018-1294-3. Epub 2018 May 14.

DOI:10.1007/s10147-018-1294-3
PMID:29761306
Abstract

BACKGROUND

Recently, the genetic alterations associated with tumor progression and impaired host immunity against transformed cells draw increased attention. Here, we characterized the differential gene expression patterns and protein expression in tumor-free lymph node from recurrent and non-recurrent tumors to identify independent prognostic markers for oral squamous cell carcinoma (OSCC).

METHODS

A cDNA microarray analysis was performed to identify the differentially expressed genes in regional tumor-free lymph nodes from OSCC patients with and without recurrence. Then, the protein expression of the selected genes was analyzed by immunohistochemistry in 60 OSCC patients to determine their association with survival.

RESULTS

Widespread down-regulation of genes involved in antigen processing and recognition in lymph nodes was a distinctive feature. In univariate Kaplan-Meier analysis, lower expression of CD40L and CD80 in tumor-free lymph nodes was significantly correlated with poorer survival. In multivariate Cox regression analysis, CD40L was identified as an independent prognostic marker of disease-free survival.

CONCLUSION

Our data indicate that impaired host immunity (decreased CD40L expression) along with the TNM staging might be an important factor determining the prognosis of OSCC.

摘要

背景

最近,与肿瘤进展和宿主对转化细胞免疫功能受损相关的遗传改变引起了越来越多的关注。在这里,我们对复发性和非复发性肿瘤无肿瘤淋巴结中的差异基因表达模式和蛋白表达进行了特征分析,以确定口腔鳞状细胞癌(OSCC)的独立预后标志物。

方法

我们通过 cDNA 微阵列分析鉴定了复发性和非复发性 OSCC 患者无肿瘤淋巴结中的差异表达基因。然后,通过免疫组织化学分析 60 例 OSCC 患者中选定基因的蛋白表达情况,以确定它们与生存的相关性。

结果

广泛下调与抗原加工和识别相关的基因是淋巴结的一个显著特征。在单变量 Kaplan-Meier 分析中,无肿瘤淋巴结中 CD40L 和 CD80 的低表达与较差的生存显著相关。在多变量 Cox 回归分析中,CD40L 被确定为无病生存的独立预后标志物。

结论

我们的数据表明,宿主免疫功能受损(CD40L 表达降低)以及 TNM 分期可能是决定 OSCC 预后的一个重要因素。

相似文献

1
Low expression of CD40L in tumor-free lymph node of oral cavity cancer related with poor prognosis.口腔癌无肿瘤淋巴结中 CD40L 的低表达与预后不良相关。
Int J Clin Oncol. 2018 Oct;23(5):851-859. doi: 10.1007/s10147-018-1294-3. Epub 2018 May 14.
2
High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.高HMGA2表达与口腔鳞状细胞癌无复发生存期缩短及总生存期差相关。
Anticancer Res. 2017 Apr;37(4):1891-1899. doi: 10.21873/anticanres.11527.
3
Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.组织蛋白酶 K 与口腔鳞状细胞癌的淋巴结转移和不良预后相关。
BMC Cancer. 2018 Apr 5;18(1):385. doi: 10.1186/s12885-018-4315-8.
4
Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma.神经细胞黏附分子 1(CNTN1)的表达与局部淋巴结转移相关,是口腔鳞状细胞癌患者预后的一个新的预测指标。
Mol Med Rep. 2012 Aug;6(2):265-70. doi: 10.3892/mmr.2012.910. Epub 2012 May 9.
5
Predictive markers for delayed lymph node metastases and survival in early-stage oral squamous cell carcinoma.早期口腔鳞状细胞癌中延迟性淋巴结转移和生存的预测标志物。
Head Neck. 2017 Apr;39(4):694-701. doi: 10.1002/hed.24667. Epub 2016 Dec 22.
6
High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.Naa10p的高表达与淋巴结转移相关,并预示口腔鳞状细胞癌的良好预后。
Tumour Biol. 2016 May;37(5):6719-28. doi: 10.1007/s13277-015-4563-z. Epub 2015 Dec 9.
7
Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.miR-448 在口腔鳞状细胞癌中的表达与预后相关。
BMC Cancer. 2020 Aug 12;20(1):756. doi: 10.1186/s12885-020-07243-z.
8
High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.TROP2的高表达与口腔鳞状细胞癌的不良预后相关。
Pathol Res Pract. 2018 Oct;214(10):1606-1612. doi: 10.1016/j.prp.2018.07.017. Epub 2018 Jul 25.
9
Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma.淋巴结比率是口腔鳞状细胞癌的独立预后因素。
Head Neck. 2011 Sep;33(9):1245-51. doi: 10.1002/hed.21600. Epub 2010 Oct 21.
10
KiSS-1 expression in oral squamous cell carcinoma and its prognostic significance.亲吻素-1在口腔鳞状细胞癌中的表达及其预后意义。
APMIS. 2016 Apr;124(4):291-8. doi: 10.1111/apm.12507. Epub 2016 Jan 25.

引用本文的文献

1
A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma.一个 13 基因标志物,用于预测肺鳞癌的预后和免疫治疗反应。
Sci Rep. 2022 Aug 11;12(1):13646. doi: 10.1038/s41598-022-17735-6.
2
Changes in immune markers in tumor-free lymph node and peripheral blood of malignant head and neck cancer patients.恶性头颈癌患者无瘤淋巴结及外周血中免疫标志物的变化。
Transl Cancer Res. 2019 Aug;8(4):1523-1530. doi: 10.21037/tcr.2019.07.35.
3
A novel seven-gene panel predicts the sensitivity and prognosis of head and neck squamous cell carcinoma treated with platinum-based radio(chemo)therapy.

本文引用的文献

1
PTPROt maintains T cell immunity in the microenvironment of hepatocellular carcinoma.PTPROt 维持肝癌微环境中的 T 细胞免疫。
J Mol Cell Biol. 2015 Aug;7(4):338-50. doi: 10.1093/jmcb/mjv047. Epub 2015 Jun 27.
2
Multifunctional CD40L: pro- and anti-neoplastic activity.多功能CD40L:促肿瘤和抗肿瘤活性。
Tumour Biol. 2014 Oct;35(10):9447-57. doi: 10.1007/s13277-014-2407-x. Epub 2014 Aug 13.
3
Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death.
一个包含七个基因的新型面板可预测头颈部鳞状细胞癌患者对铂类放化疗的敏感性和预后。
Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3523-3531. doi: 10.1007/s00405-021-06717-5. Epub 2021 Mar 8.
4
Accelerated elimination of human cancer cells by a CD40 agonist antibody combined with a PD-1 antagonist in CD4-depleted mice.在CD4缺失的小鼠中,CD40激动剂抗体与PD-1拮抗剂联合使用可加速人类癌细胞的清除。
Oncol Lett. 2019 Dec;18(6):5889-5896. doi: 10.3892/ol.2019.10991. Epub 2019 Oct 14.
CD40L的靶向递送促进抗原呈递细胞的局限性激活并诱导癌细胞死亡。
Mol Cancer. 2014 Apr 17;13:85. doi: 10.1186/1476-4598-13-85.
4
STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma.STAG2 是胰腺导管腺癌中具有临床相关性的肿瘤抑制因子。
Genome Med. 2014 Jan 31;6(1):9. doi: 10.1186/gm526. eCollection 2014.
5
Frequent truncating mutations of STAG2 in bladder cancer.膀胱癌中 STAG2 的频繁截短突变。
Nat Genet. 2013 Dec;45(12):1428-30. doi: 10.1038/ng.2800. Epub 2013 Oct 13.
6
T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment.肿瘤微环境中的 T 细胞失能、耗竭、衰老和干性。
Curr Opin Immunol. 2013 Apr;25(2):214-21. doi: 10.1016/j.coi.2012.12.003. Epub 2013 Jan 6.
7
Aberrant methylation of the PTPRO gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients.外周血 PTPRO 基因异常甲基化作为食管鳞癌患者的潜在生物标志物。
Cancer Lett. 2012 Feb 28;315(2):138-44. doi: 10.1016/j.canlet.2011.08.032. Epub 2011 Sep 12.
8
Mutational inactivation of STAG2 causes aneuploidy in human cancer.STAG2 基因突变导致人类癌症的非整倍体。
Science. 2011 Aug 19;333(6045):1039-43. doi: 10.1126/science.1203619.
9
T cell exhaustion.T 细胞耗竭。
Nat Immunol. 2011 Jun;12(6):492-9. doi: 10.1038/ni.2035.
10
Serum IL10 and circulating CD4(+) CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma.血清白细胞介素 10 和循环 CD4(+) CD25(high) 调节性 T 细胞数量作为头颈部鳞状细胞癌患者临床结局和生存的预测指标。
Head Neck. 2011 Mar;33(3):415-23. doi: 10.1002/hed.21464.